Jing Wang
The University of Texas MD Anderson Cancer Center · 1,168 works · 34,626 citations · h-index 86
Top works
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
- Phosphatidylinositol 4 Phosphate Regulates Targeting of Clathrin Adaptor AP-1 Complexes to the Golgi
- The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
- Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
- LBA15 Amivantamab plus chemotherapy (with or without lazertinib) vs chemotherapy in EGFR-mutated advanced NSCLC after progression on osimertinib: MARIPOSA-2, a phase III, global, randomized, controlled trial
- The role of MLL in hematopoiesis and leukemia
- Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
- Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1
- Crystal structure of the clathrin adaptor protein 1 core
- SNARE Proteins: One to Fuse and Three to Keep the Nascent Fusion Pore Open
- PI4P Promotes the Recruitment of the GGA Adaptor Proteins to the Trans-Golgi Network and Regulates Their Recognition of the Ubiquitin Sorting Signal
- Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647
- ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
- Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers
- Mesenchymal Stem Cells Regulate Blood-Brain Barrier Integrity Through TIMP3 Release After Traumatic Brain Injury
- Transmembrane Biogenesis of Kv1.3
- Critical role of PIP5KIγ87 in InsP3-mediated Ca2+ signaling
- Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer